Leading thesmall moleculeRevolution
Leading
the smallmoleculeRevolution
the small
Committed to patient impact
Our drug discovery engine has yielded multiple novel drug candidates that are being evaluated in clinical trials.
Transforming drug discovery
Chemoproteomics provides the lens for an expansive view of the human proteome that enables us to find novel ways to develop small molecules with therapeutic potential.
We are driven by scientific curiosity, creativity,
and an urgent drive for innovation
Vividion’s unique chemoproteomics platform allows us to identify and pursue novel strategies to target pathways that contribute to human disease. One of the most rewarding aspects of this drug discovery approach is the ability to explore hypotheses related to our therapeutic strategies, in hopes of finding the optimal ways to bring our treatments to patients.”
– Joseph Klebba, Ph.D., Associate Director, Oncology Early Discovery Sciences
Joseph Klebba
Associate Director, Oncology Early Discovery Sciences